The recommendation was given after reviewing very rare cases of unusual blood clots occurring in the United States after the vaccine.
Six cases of cerebral venous sinus thrombosis (CVST) have occurred in the United States, most of them in association with low levels of blood platelets.
Earlier, Johnson and Johnson had started shipping vaccines to countries in the European Union.
The company then requested that the deployment be delayed to give time to clarify.
However, the EMA said the vaccine could be used without restriction and that the vaccine’s benefits in preventing COVID-19 outweighed the risks of side effects.
U.S. regulatory authorities suspended use of the vaccine earlier, after some 6.8 million people received the vaccine there.
Short Link: https://wp.me/pcj2iU-3yZ2
- NYCN commends PAN Chairman’s contribution to youths devt. in Nasarawa
- Clergyman canvasses promotion of peaceful coexistence through effective reporting
- Photo Press Release: Call for Nominations – Rugby Africa Inaugural Media and Photography Award
- Long working hours cause 745,000 deaths – UN study
- Call for Nominations: Rugby Africa Inaugural Media and Photography Award
- NAF reaffirms commitment to protect territorial integrity
- Patriots rally to defeat Rivers Hoopers in Basketball Africa League opening
- Fostering World Peace requires tolerance, inclusion, reconciliation – Kallon
- COVID: NCDC records lowest daily count with 7 new cases on May 16